Skip to main content
Journal cover image

Contrast-enhanced magnetic resonance imaging (CE-MRI) parameters have predictive value in estimating response of locally advanced breast cancer (LABC) patients to neoadjuvant (NA) chemotherapy (CT) and hyperthermia (HT)

Publication ,  Conference
Craciunescu, OI; Blackwell, KL; Jones, EL; Vujaskovic, Z; Rosen, EL; Wong, TZ; MacFall, JR; Liotcheva, V; Yu, D; Lora-Michels, M; Prosnitz, LL ...
Published in: BREAST CANCER RESEARCH AND TREATMENT
January 1, 2004

Duke Scholars

Published In

BREAST CANCER RESEARCH AND TREATMENT

ISSN

0167-6806

Publication Date

January 1, 2004

Volume

88

Start / End Page

S18 / S19

Location

San Antonio, TX

Publisher

SPRINGER

Conference Name

27th Annual Charles A Colman San Antonio Breast Cancer Symposium

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Craciunescu, O. I., Blackwell, K. L., Jones, E. L., Vujaskovic, Z., Rosen, E. L., Wong, T. Z., … Dewhirst, M. W. (2004). Contrast-enhanced magnetic resonance imaging (CE-MRI) parameters have predictive value in estimating response of locally advanced breast cancer (LABC) patients to neoadjuvant (NA) chemotherapy (CT) and hyperthermia (HT). In BREAST CANCER RESEARCH AND TREATMENT (Vol. 88, pp. S18–S19). San Antonio, TX: SPRINGER.
Craciunescu, O. I., K. L. Blackwell, E. L. Jones, Z. Vujaskovic, E. L. Rosen, T. Z. Wong, J. R. MacFall, et al. “Contrast-enhanced magnetic resonance imaging (CE-MRI) parameters have predictive value in estimating response of locally advanced breast cancer (LABC) patients to neoadjuvant (NA) chemotherapy (CT) and hyperthermia (HT).” In BREAST CANCER RESEARCH AND TREATMENT, 88:S18–19. SPRINGER, 2004.
Craciunescu OI, Blackwell KL, Jones EL, Vujaskovic Z, Rosen EL, Wong TZ, et al. Contrast-enhanced magnetic resonance imaging (CE-MRI) parameters have predictive value in estimating response of locally advanced breast cancer (LABC) patients to neoadjuvant (NA) chemotherapy (CT) and hyperthermia (HT). In: BREAST CANCER RESEARCH AND TREATMENT. SPRINGER; 2004. p. S18–9.
Craciunescu OI, Blackwell KL, Jones EL, Vujaskovic Z, Rosen EL, Wong TZ, MacFall JR, Liotcheva V, Yu D, Lora-Michels M, Prosnitz LL, Samulski TV, Dewhirst MW. Contrast-enhanced magnetic resonance imaging (CE-MRI) parameters have predictive value in estimating response of locally advanced breast cancer (LABC) patients to neoadjuvant (NA) chemotherapy (CT) and hyperthermia (HT). BREAST CANCER RESEARCH AND TREATMENT. SPRINGER; 2004. p. S18–S19.
Journal cover image

Published In

BREAST CANCER RESEARCH AND TREATMENT

ISSN

0167-6806

Publication Date

January 1, 2004

Volume

88

Start / End Page

S18 / S19

Location

San Antonio, TX

Publisher

SPRINGER

Conference Name

27th Annual Charles A Colman San Antonio Breast Cancer Symposium

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences